Bio shares anaylst is bagging PGL for not securing a licensing deal with big pharma two years ago to see it through Phase 111.
Got news for you buddy, PGL has secured the cash by itself to conduct very expensive Phase 111 without kissing big pharma butt.
So when the news comes in , guess who won't be sharing the pie with big Pharma, yep you guessed right , PGL.
I think PGL has achieved what few have.
DYOR
